Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice

Injury

Volumn 43, Issue 7, 2012, Pages 1052-1057

  Madsen, Christian Medom ^a   Jørgensen, Henrik Løvendahl ^a   Lind, Bent ^b   Ogarrio, Henning Worm ^a   Riis, Troels ^a   Schwarz, Peter ^c,d   Duus, Benn Rønnow ^a   Lauritzen, Jes Bruun ^a,d  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Copenhagen General Practitioners Laboratory ^*  (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Calcium; Hip fracture; Mortality; PTH; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CALCIUM; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; GENERAL PRACTICE; HIP FRACTURES; HOSPITAL MORTALITY; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; PARATHYROID HORMONE; PROSPECTIVE STUDIES; VITAMIN D;

EID: 84862857200     PISSN: 00201383     EISSN: 18790267     Source Type: Journal    
DOI: 10.1016/j.injury.2011.12.025     Document Type: Article

References (50)

1. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 2009;20:1633-50.
2. Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009;170:1290-9.
3. Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573-9.
4. Foss NB, Palm H, Krasheninnikoff M, Kehlet H, Gebuhr P. Impact of surgical complications on length of stay after hip fracture surgery. Injury 2007;38:780-4. (Pubitemid 46879727)
5. Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010;152:380-90.
6. Lawrence VA, Hilsenbeck SG, Noveck H, Poses RM, Carson JL. Medical complications and outcomes after hip fracture repair. Arch Intern Med 2002;162:2053-7. (Pubitemid 35168213)
7. Radcliff TA, Henderson WG, Stoner TJ, Khuri SF, Dohm M, Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008;90:34-42.
8. Vestergaard P, Rejnmark L, Mosekilde L. Has mortality after a hip fracture increased? J Am Geriatr Soc 2007;55:1720-6. (Pubitemid 350043786)
9. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25- hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008;149:242-50.
10. Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A. Primary hyperparathyroidism in elderly patients with hip fracture. J Bone Miner Metab 2004;22: 491-5. (Pubitemid 39248845)
11. Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, et al. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006;29: 809-13. (Pubitemid 44869426)
12. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 2009;24:693-701.
13. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501. (Pubitemid 32762324)
14. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res 2008;23:143-50.
15. Roddam AW, Neale R, Appleby P, Allen NE, Tipper S, Key TJ. Association between plasma 25-hydroxyvitamin D levels and fracture risk: the EPIC-Oxford study. Am J Epidemiol 2007;166:1327-36. (Pubitemid 350129418)
16. Sahota O, Gaynor K, Harwood RH, Hosking DJ. Hypovitaminosis D and 'functional hypoparathyroidism' - the NoNoF (Nottingham Neck of Femur) study. Age Ageing 2001;30:467-72. (Pubitemid 34071485)
17. von Muhlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int 2005;16:1721-6. (Pubitemid 41790881)
18. Barone A, Giusti A, Pioli G. Hypovitaminosis D and secondary hyperparathyroidism in the elderly: risk factors for hip fracture or markers of frailty? Osteoporos Int 2007;18:1561-2. discussion 1563.
19. Barnard K, Colon-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 2010;8:4-33.
20. Cawthon PM, Parimi N, Barrett-Connor E, Laughlin GA, Ensrud KE, Hoffman AR, et al. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab 2010;95:4625-34.
21. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
22. Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am J Cardiol 2010;106:798-805.
23. Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004;89:5477-81. (Pubitemid 39518428)
24. Shardell M, Hicks GE, Miller RR, Kritchevsky S, Andersen D, Bandinelli S, et al. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009;64:69-75.
25. Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM. Vitamin D deficiency and frailty in older Americans. J Intern Med 2010;268:171-80.
26. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. 25-Hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients. J Bone Miner Metab 2006;24:42-7. (Pubitemid 41821502)
27. Fisher A, Goh S, Srikusalanukul W, Davis M. Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy. Calcif Tissue Int 2009;85:301-9.
28. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 2008;73:1296-302. (Pubitemid 351693159)
29. Schumock GT, Andress DL, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract 2009;113:c54-61.
30. Bjorkman M, Sorva A, Tilvis R. Parathyroid hormone as a mortality predictor in frail aged inpatients. Gerontology 2009;55:601-6.
31. Premaor MO, Scalco R, da Silva MJ, Furlanetto TW. Secondary hyperparathyroidism is associated with increased risk of hospitalization or death in elderly adults living in a geriatric institution. Gerontology 2009;55:405-10.
32. Chen JS, Sambrook PN, March L, Cameron ID, Cumming RG, Simpson JM, et al. Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf) 2008;68:290-8.
33. Bjorkman MP, Sorva AJ, Tilvis RS. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol 2008;158:749-53. (Pubitemid 351639614)
34. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009;119:2765-71.
35. Zittermann A, Gummert JF, Borgermann J. Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care 2009;12:634-9.
36. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37.
37. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9. (Pubitemid 351930842)
38. Kuroda T, Shiraki M, Tanaka S, Ohta H. Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone 2009;44:168-72.
39. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009;71:666-72.
40. Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr 2011;50:305-12.
41. Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010;92:841-8.
42. Bruce DG, St John A, Nicklason F, Goldswain PR. Secondary hyperparathyroidism in patients from Western Australia with hip fracture: relationship to type of hip fracture, renal function, and vitamin D deficiency. J Am Geriatr Soc 1999;47:354-9. (Pubitemid 29113852)
43. Rejnmark L, Vestergaard P, Brot C, Mosekilde L. Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics. Clin Endocrinol (Oxf) 2008;69:29-35. (Pubitemid 351847277)
44. Stein MS, Flicker L, Scherer SC, Paton LM, O'Brien ML, Walton SC, et al. Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf) 2001;54:583-92. (Pubitemid 34208901)
45. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35:312-9. (Pubitemid 38789179)
46. Sakuma M, Endo N, Oinuma T, Hayami T, Endo E, Yazawa T, et al. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006;17: 1608-14. (Pubitemid 44477620)
47. Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 2008;69:1-19. (Pubitemid 351863591)
48. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17(Suppl. 2):N18-N23. (Pubitemid 35222308)
49. Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 2010;39:203-9.
50. Johnston AT, Barnsdale L, Smith R, Duncan K, Hutchison JD. Change in long-term mortality associated with fractures of the hip: evidence from the scottish hip fracture audit. J Bone Joint Surg Br 2010;92:989-93.